Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
5.56M
-
Shares change
-
+70.4K
-
Total reported value, excl. options
-
$88M
-
Value change
-
+$1.16M
-
Number of buys
-
21
-
Number of sells
-
-19
-
Price
-
$15.84
Significant Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q2 2014
46 filings reported holding ESPR - Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2014.
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.56M shares
of 207M outstanding shares and own 2.68% of the company stock.
Largest 10 shareholders include Aisling Capital LLC (2.05M shares), Pentwater Capital Management LP (1M shares), WASATCH ADVISORS INC (604K shares), Polar Capital LLP (326K shares), BlackRock Fund Advisors (305K shares), VANGUARD GROUP INC (159K shares), MORGAN STANLEY (157K shares), Iguana Healthcare Management, LLC (125K shares), DEUTSCHE BANK AG\ (112K shares), and FMR LLC (83.8K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.